A B S T R A C T Human sera were found to contain factors that stimulate and factors that inhibit porphyrin formation by cultured avian liver cells. The capacity of sera to stimulate or inhibit porphyrin formation varied in different hormonal states and in the porphyrias. Sera from 31 post partum women, eight of whom were not lactating, inhibited porphyrin formation to a mean level 30% below the level in control cultures and also inhibited drug and steroid stimulation of porphyrin formation. In contrast, mean porphyrin formation compared to control cultures was increased between 9 and 21% by sera from 52 normal subjects, 16 women on oral contraceptives, and 11 pregnant women. It was increased 193% by sera from nine subjects with acute intermittent porphyria and 172% by sera from 13 subjects with porphyria cutanea tarda. Heated sera or ethanol extracts of sera from all groups of subjects further increased the mean porphyrin stimulation by sera and, for the post partum subjects, eliminated the inhibitory effect. Ethanol extracts of sera from 28 oral contraceptive-treated women caused significantly greater mean stimulation of porphyrin formation than did extracts of sera from 30 normal women. While sera from 17 out of 22 porphyric subjects contained both stimulatory and inhibitory factors, 5 out of 22 had no evidence of an inhibitory component. There appeared to be heterogeneity in the occurrence of the factors among porphyrics.
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The factor(s) in sera responsible for porphyrin stimulation were heat-stable and insensitive to trypsin; were present in the supernates after ethanol precipitation of plasma proteins; were extractable in ethyl acetate and nondialyzable; and they migrated with the albumincontaining fraction of serum during electrophoresis. INTRODUCTION Extracts of plasma from patients with acute intermittent porphyria (AIP)1 and from women ingesting oral contraceptive steroids have been found to stimulate porphyrin formation in cultured chick embryo liver cells (1) . The chemical nature of the factor, or factors, in sera that increase the accumulation of porphyrins has not been identified. Among the many different drugs and steroids that have been shown to stimulate porphyrin formation, both in cultured liver cells and in animals and humans in vivo (2) (3) (4) (5) (6) (7) (8) (9) , steroid hormones and their metabolites are the only compounds occurring naturally in man. Well-documented variations in clinical activity of porphyria with respect to sex and endogenous hormonal alterations (10) , and evidence of increased urinary excretion of steroids with the capacity to stimulate porphyrins in AIP (11, 12) , make particularly interesting the possibility that circulating hormonal substances are involved in the pathogenesis of porphyria.
The present study was designed to examine the effects of sera fronm subjects in a variety of hormonial states on liver cell porphyrin accumulation, and to compare these to the effects of sera from normal and porphyric subjects. We found that human sera contain factors that stimulate and factors that inhibit porphyrin formation by liver cells. The amount and relative proportion of those factors vary in different hormonal states anid in the porphyrias. This report describes these findinigs and our progress in separating and characterizing the serum conmponents responsible for the stiniulatory and inihibitor) plhenonlelnea.
METHODS
Subjects aitd blood samples. The subjects studied included 52 normal men and women, 28 women ingesting oral contraceptive steroids, 11 pregnant women, 31 post partum women, nine patients with AIP, and 13 patients with porphyria cutanea tarda (PCT). The normal subjects were composed of two groups. The first group, designated "normal subjects A," consisted of 33 women between the ages of 20 and 35 who attended the obstetrics and gynecology clinic at The New York Hospital for routine examinations. Their sera and sera extracts were used for the data in Fig. 1 . The second group, designated "normal subjects B," consisted of 11 women and eight men, between the ages of 21 and 35, who were laboratory personnel and volunteers for this study. Their sera were used for the data in Fig. 4 . All normal subjects were healthy and denied having ingested any drugs within the month preceding the study.
The contraceptive-treated group consisted of 28 women, ages The pregnant group consisted of 11 women, ages 23-32, attending the prenatal clinic at The New York Hospital. They were all between the 30th and 38th wk of gestation and, therefore, were all in the 3rd trimester. Six were primigravidas and five were gravida twos.
Sera were obtained from 20 post partum women, 3-4 days after normal spontaneous deliveries at The New York Hospital. Most of the women selected (17 subjects) were lactating, thus excluding any effect from hormones given to suppress lactation. Sera from three nonlactating women were also examined. Blood samples were also obtained at routine examinations, 6 wk post partum, from 11 women, 6 of whom had breast fed their infants and five of whom had not. The post partum women were between 14-and 25-yr old. Of the 31 subjects in this group, there were 17 primigravidas, 9 gravida twos, 2 gravida threes, and one each gravida four, five, and seven.
9 subjects with AIP and 13 with PCT were patients at the Rockefeller University Hospital or University Hospital (New York University). Diagnoses were based on characteristic history, clinical observations, and measurements of urinary porphyrins and porphyrin precursors, according to the criteria described by Marver and Schmid (10) . The AIP patients included one man and eight women, ranging in age from 22 to 56. The PCT patients included nine men and four women; they ranged in age from 30 to 65. During the study, two AIP inpatients received meperidine for pain. The others with AIP and those with PCT had received no drugs within at least 1 mo before giving the serum samples.
Blood was drawn into tubes without anticoagulants. Clots were allowed to form for 2 h, and then the samples were spuni at 2,000 rpm for 20 mim at 4°C. 2-ml aliquots of sera were placed in -lass vials and kept at 0°C until used.
Experiiettal miethods. Chick embryo liver cells were grown in primary cultures according to the method of Granick (2) . In brief, livers from 14-or 15-day-old chick embryos were minced and then incubated at 37'C for 20-30 min in 9 ml 1% trypsin (Gallard-Schlesinger Chemical Mfg. Corp., Carle Place, N. Y.) and 3 ml 1o pangestin (Difco Laboratories, Detroit, Mich.). Approximately 5 X 105 cells were added to 19 x 65-mm glass shell vials, in each of which a glass cover slip had been placed. Eagle's powdered basal medium (Grand Island Biological Co., Grand Island, N. Y.) in distilled water was supplemented per liter, as follows: 3.0 g sodium bicarbonate, 100 ml fetal bovine serum (Microbiological Associates, Inc., Bethesda, Md.), 10 ml amino acid concentrate (Microbiological Associates, Inc.), and antibiotics (streptomycin, 100 mg, penicillin, 100,000 U, and Mycostatin [E. R. Squibb and Sons, Princeton, N. J.], 25,000 U). pH was adjusted to 7.4. 1 ml medium was added to each vial. The vials were incubated at 37°C in an atmosphere of 95% air and 5%
CO2 for 24 h, after which the media were replaced with fresh media, and additions to the vials (sera, extracts of sera, modified sera, drugs) were made. The vials were incubated for an additional 20-24 h and then frozen.
Porphyrins were measured by the method of Granick (2), modified by Sassa. The modifications involved lyophilizing the cells and media, measuring total porphyrin accumulation in the combined cells and media (rather than in the cells alone), and using an R-136 photomultiplier tube to enhance red-light sensitivity of the fluorimeter. Porphyrins were extracted from the lyophilized material by adding 5 ml of a solution of 1 N perchloric acid: methanol (1: 1, vol/vol) effects of sera on porphyrin formation, or to interference by sera with the extraction or measurement of porphyrins.
Two types of controls were routinely included in each culture experiment. The first was the inclusion of 10-15 vials to which no additions were made, based on our observation that 100 Al of water, 0.9% saline, 0.1 M phosphate buffer at pH 7.4, Earle's balanced salt solution, and the residue of 10 ml evaporated ethanol in 1 ml water, added to 1 ml medium, had no effect on porphyrin accumulation. The second control was the inclusion of 10-15 vials containing 30 Aig allylisopropylacetamide (AIA), a drug which is a known stimulator of porphyrin formation. The vials with AIA were included in each experiment, both to ensure that the cells were capable of increasing porphyrin formation in response to a drug and to allow measurement of the extent of responsiveness of each particular cell culture preparation. In early experiments we included several doses of AIA to construct AIA doseresponse curves but later used multiple vials with one standard dose of AIA (30 , 30 ,g AIA exceeded 10 times control, the serum responses were correspondingly decreased by the correction procedure. For inhibitory effects of sera in cultures in which porphyrin formation was stimulated by AIA, the data were corrected as described above. For inhibitory effects in control cultures, no adjustments were made because the amount of inhibition of the already low porphyrin levels in control cultures could not be shown to be related to the induction response of the particular culture to AIA. Statistical significance of differences from the appropriate control and statistical significance of differences in mean responses of sera from different groups of subjects were determined by Student's t test. Differences were accepted as being statistically significant if the P value was < 0.05.
The normalized data are presented for purposes of comparing results from several cell culture experiments. We wish to emphasize, however, that the normalization procedure did not result in any qualitative or any statistically significant quantitative changes in the findings, since the mean results when calculated from the normalized data were, in no instance, significantly different from the results calculated from the raw data. The normalization procedure demonstrates that variations in responsiveness of cell culture preparations cannot account for the findings reported.
Six lots of fetal bovine sera were used in these experiments. Each lot had been pretested and accepted if it had no harmful effect on cell morphology and if it permitted at least a 10-fold stimulation of porphyrin formation by 30 ,Ag AIA. There were no significant differences in the range of responses to AIA in cell cultures using the different lots of bovine sera. Moreover, sera from each group of subjects were examined with each lot of bovine sera, and the behavior, of the sera remained true to type, i.e., extracts of sera from oral contraceptive-treated and porphyric subjects increased porphyrin accumulation, while post partum sera inhibited porphyrin formation, regardless of the lot of sera used. Sera from eight individuals were tested in cell culture experiments using two-four different lots of bovine sera. The mean difference in response was only 15%±o0.03 (SE). Therefore, since different lots of fetal bovine sera did not introduce a major variable into the system, no adjustment was made for the different lots of fetal bovine sera. 100 Al fetal bovine sera, an amount equivalent to the amount of human sera usually added to cultures, did not affect control or AIA-induced porphyrin formation. 100 /4 fetal bovine sera heated to 60'C for 10 min resulted in porphyrin formation 1.21 times the level in control cultures.
8-Aminolevulinic acid synthetase (ALAS) activity was measured in the mitochondrial subfractions from liver, cells grown in 10-cm Petri dishes (Falcon Plastics, Div. of Bioquest, Oxnard, Calif.) containing 20 times the amount of media, cells, and sera used in the vials (13) . Reactions were carried out in duplicate in incubation volumes of 200 pl and were stopped with 200 ,ul 10% trichloroacetic acid. Each reaction mixture contained one-fifth of the mitochondrial (10,000g) pellet derived from cells scraped together from two replicate Petri dishes. A zero-time control was always included. DNA was measured by the method of Kissane and Robins (114). Hemoglobin was measured by difference spectroscopy, using the method of Levere, Swerdlow, and Garavoy (15) .
Ethanol extracts of sera were prepared by adding 10 vol of cold absolute ethanol to 1 or 2 ml sera (1) . After centrifugation at 2,000 rpm for 10 min, the ethanolic supernate was removed and the ethanol evaporated in vacuo at 37°C. The dry residue was brought back to the original serum volume with Earle's balanced salt solution. It is this resolubilized dried ethanolic supernate that is referred to as "ethanol extract" in the text. Usually, 100 IAI sera, ethanol extracts of sera, or sera otherwise modified (see below) were added per culture vial.
To extract and partially purify the proteins precipitated by ethanol, the precipitates were extracted twice with 4 vol of 10%o ammonium acetate in 70%o ethanol. 2 vol of 10% ammonium acetate in 100%o ethanol were added to the combined supernates, which were allowed to remain at 4°C overnight to reprecipitate the protein (16 (18) .
RESULTS
Effects of sera and sera extracts on liver cell porphyrin formation. Fig. 1 shows the effects on liver cell porphyrin formation of 100 Al sera and 100 Al ethanol extracts of sera from normal women, women taking oral contraceptives, pregnant women, and post partum women. Sera from normal subjects A were used. Mean porphyrin formation +SE, compared to control cultures by sera were as follows: 33 normals, 1.21-+-0.06; 16 contraceptive-treated, 1.09+0.08; 11 pregnant, 1.18± 0.12; 20 post partum, 0.70±0.04. Thus, sera from normal, contraceptive-treated, and pregnant women caused a small stimulation of porphyrin formation, with no significant differences between the groups. In contrast, post partumin sera inhibited porphyrin formation. The inhibition was statistically significant compared to all other groups at the P < 0.001 level.
Mean porphyrin levels attained after the addition of ethanol extracts of sera from all groups of subjects were higher than the levels elicited by untreated sera. Mean porphyrin formation 4±SE, compared to control cultures by ethanol extracts of sera, were as follows:
30 normals, 1.26+0.09; 28 contraceptive-treated, 1.57+ 0.15; 11 pregnant; 1.37±0.10; and 20 post partum, 1.36+ 0.15. Mean porphyrin formation after the addition of ethanol extracts of sera from contraceptive-treated women was significantly higher than mean porphyrin formation after the addition of extracts from sera of normal women (P < 0.05). There were no significant correlations between the effects of sera on porphyrin formation and the time elapsed between drawing the blood sample and eating, day of the menstrual cycle. type of oral contraceptive used or the total length of time it was used, week of gestation, drugs given at or after delivery, nor parity of individual women.
Scra zcthich inihibit porphyrin formation. Untreated sera from post partumi women inhibited liver cell porphyrin formation in contrast to all other sera tested; but no inhibitory activity was evident in ethanol extracts of post partunt sera. Porphyrin accumulation was decreased by sera from 17 out of 20 women, 3-4 days post partumi. Sera from tlhree nonlactating women inhibited porphyrin formationi to a mean level 30%' less than that of control cuilttures, as did the sera from lactating women.
Of the serum samples obtained from 11 mothers at the 6-wk post partumiii checkup, all inhibited porphyrin formation. Mean porphyrin formation in cultures to which sera from six lactating women were added was 0.73±0.03 (SE) times the level in control cultures; while in cultures to which sera from five nonlactating women were added, the mean porphyrin accumulation was 0.71±0.03 (SE) times the level in control cultures. Those levels were not significantly different from each other or from the mean inhibition by sera from women 3-4 days post partumn. AMenses had recurred in one subject; her serum was, nevertheless, also inhibitory. Thus, the capacity of sera to inhibit porphyrin formation persisted at least up to 6 wk post partum, was not restricted to lactating women, and did not disappear with the onset of menses in one subject. To amplify the inhibitory effect, 100 A post partum sera, together with 30 pg AIA, were added to cultures. Mean porphyrin formation in cultures to which 23 post partum sera were added was 0.40±0.06 (SE), while in cultures to which sera from 12 normal women were added, it was 0.91±0.08 (SE) of the AIA-induced controls. The difference was significant at the P < 0.001 level. Post partumn sera also inhibited the stimulation of porphyrin formation by several different drugs and steroid hormones, including secobarbital (Seconal, Eli Lilly and Co., Indianapolis, Ind.), mephenytoin (Mesantoin, Sandoz Pharmaceuticals, East Hanover, N. J.), 3,5-diethyl-1,4-4dihydrocollidine dicarboxylate (DDC), 5P-androstan-3a-ol-17-one (etiocholanolone) and 5f-androstan-3a-ol-1 1,20-dione (11-ketopregnanolone). The results of a characteristic experiment are shown in Table I .
The effect of sera which inhibited porphyrin formation on ALAS activity in liver cell cultures was measured (Table II) . Compared to control cultures, sera from two post partum subjects, which had inhibited porphyrin formation by 54 and 32%, depressed ALAS activity by 61 and 29%, respectively, whereas a serum sample from a normal male that had not inhibited porphyrin formation did not inhibit ALAS. The depression of ALAS activity was not attributable to a direct inhibitory effect of the sera on ALAS, since the same sera added to chick embryo liver homogenates in vitro did not alter the activity of control or drug-induced ALAS.
When 5 pg 8-aminolevulinic acid (ALA) was added to the culture vials, a mean increase of p.orphyrins to 20 times the level in control cultures resulted. Sera from eight post partum subjects caused a mean inhibition of conversion of 5 ug ALA to porphyrins of 34%±0.06 (SE). Sera from the same eight subjects inhibited the induction of porphyrin formation by 30 pg AIA, by 55%+0.06 (SE). The decrease in AIA induction was significantly greater than the decrease in ALA conversion (P < 0.05). Recovery of inhibitory activity in precipitates after ethanol extraction of sera. Since inhibition of porphyrin accumulation was not evident in the ethanol extracts after precipitation of plasma proteins, an attempt was made to recover inhibitory activity in the ethanol precipitates. The precipitates were extracted, reprecipitated, and then dissolved in Earle's balanced salt solution, before being added to the cell culture preparations (see Methods). In six post partum serum samples, inhibitory activity was present in the whole serum and in the ethanol precipitates after partial purification and resolubilization, while it was absent in the ethanolic supernates. Recovery of inhibitory activity in the precipitates after ethanol extraction gave further evidence that the factor 2 responsible for the inhibition probably was a protein or a substance tightly bound to a protein and, in light of the procedure used, suggested that it might be a glycoprotein. Fig. 2 shows dose-response relationships between the amount of extracted serum protein added to the cultures and the degree of inhibition of AIA-stimulated porphyrin formation. Inhibitory effects were dose related. While the amount of inhibitory activity in different sera varied, dose-response relationships were parallel.
Heat and trypsin inactivation of inhibitory activity in serum; effect of neuraminidase. When sera from the post partum women were heated to 60°C for 10 min or 2 We recognize that one or more than one factor may be responsible for inhibition of porphyrin formation and, likewise, for stimulation of porphyrin formation. For simplicity, however, we use the terms "factor," "component," and "substance" in the singular throughout the paper. preincubated at 37°C with 0.1% trypsin for 30 min, they no longer gave any evidence of inhibiting porphyrin formation. 0.1% trypsin in Earle's balanced salt solution or water did not affect porphyrin formation when added to cultures alone. The loss of inhibition by heating to 60°C for 10 min indicated that the inhibitor was heat labile and, therefore, most likely to be a globulin rather than albumin, which is not destroyed at 600C.
When inhibitory activity was reduced or eliminated by heating, the sera increased the accumulation of porphyrins by the cultured liver cells, as compared to control cultures, indicating that something in the unheated serum had masked the presence of a heat-stable substance capable of stimulating porphyrini formation. Wavelength, nm FIGURE 3 Reduction of inhibition of porphyrin formation in post partum serum by heating or trypsin preincubation.
The fluorescence emission spectra from 560 to 700 nm of liver cell porphyrins are shown (excitation wave length, 400 nm). The middle curve shows the spectrum from cultures treated with 30 ,ug AIA. The two lower curves show the spectra from cultures to which AIA and serum (100 ,ul) or no additions were made (control cultures). The addition of serum together with AIA resulted in inhibition of porphyrin formation nearly to control levels. drug was added and in those in which porphyrin formation was increased by AIA. In order to find out whether an intact glycoprotein was required for the inhibition of porphyrin formation by sera, the effect of neuraminidase on serum inhibition of porphyrin formation was examined. Neuraminidase at 1, 2.5, and 5 U/ml had no effect on the inhibition of porphyrin formation by sera. Since 0.5 U/ml has been reported to result in 100% desialyation of 30 mg human chorionic gonadotropin (19) , the concentrations of neuraminidase used in our experiments should have been adequate to indicate neuraminidase sensitivity. The inhibitory factor was, therefore, resistant to neuraminidase. Moreover, N-acetylneuraminic acid at 1, 10, and 100 gg/vial did not inhibit control or AIA-stimulated porphyrin formation. Though this evidence does not exclude the possibility that the inhibitor may be a glycoprotein, it suggests that an intact carbohydrate moiety is not essential for the inhibitory effect.
Exclusion of heme or a known heme-binding protein as the factor responsible for inhibitory activity. Heme is the only known substance normally present in human tissue that can inhibit porphyrin formation by liver cells. Since the inhibitor was destroyed by heating, and heme is heat stable, the inhibitor could not be heme. However, since heme commonly circulates bound to protein as hemoglobin, hemopexin, or hemalbumin, we considered the possibility that the inhibitor was protein-bound heme. Hemoglobin and hemopexin' contents of inhibitory sera were no higher than those of noninhibitory sera. Moreover, the inhibitor was inactivated at 60°C, while albumin is not, and inhibitory activity was localized in the gamma globulin region of plasma, while the albumin region contained stimulatory activity. Therefore, the inhibitor does not appear to be heme bound to protein as hemoglobin, hemopexin, or hemalbumin.
Stimulatory and inhibitory activity in normal and porphyric sera. The reduction of the inhibitory activity in post partum sera by heating led us to reexamine the distribution of stimulatory and inhibitory activity in normal and porphyric sera. The effects on porphyrin formation of 100 Al unheated sera and sera heated to 60(C for 10 min, taken from nine subjects with AIP and 13 with PCT, are compared to the effects of sera from 19 normal subjects, in Fig. 4 . Normal subjects B were used in these experiments. Mean porphyrin formation +SE, compared to control cultures resulting from the addition to cultures of unheated and heated sera from the three groups, are as follows: 19 normal men and women, 1.26±0.11, 2.20± 0.24; 9 patients with AIP, 2.93+0.50, 3 In all 19 normal subjects, lheated sera produced higher levels of porphyrins than unheated sera; in 14 out of 19 the stimulation was statistically significant. There was no significant difference between the effects of sera from males and females. Thus, sera from normal individuals appeared to contain a component that inhibited and a component that stimulated porphyrin formation; heating reduced the inhibition and resulted in the display of stimulatory activity.
Untreated sera from patients with AIP and PCT caused greater mean stimulation of porphyrin formation than did heated sera from normal subjects; and heating of AIP and PCT sera caused a further increase in mean porphyrin accumulation. In 5 out of 9 subjects with AIP, and in 5 out of 13 subjects with PCT, greater stimulatory activity than that found in sera of any normal individual was present in unheated sera. Sera from the other porphyric subjects could not be distinguished from normal sera. Both the AIP subject and the PCT subject whose sera had the greatest ability to stimulate porphyrin formation were clinically symptomatic. However, among the remaining subjects, no correlation was observed between symptoms and the capacity of serum to stimulate porphyrin accumulation. No effects could be attributed to meperidine in this small sample.
Heating did not increase the capacity to stimulate porphyrin accumulation in the sera from two subjects with AIP and one with PCT. Heating sera from two other patients with PCT resulted in significantly decreased stimulation of porphyrin formation, suggesting that in certain individuals with porphyria, the inhibitory component may be mssing, and moreover, that in some porphyrics the factor responsible for stimulation of porphyrin formation may also be p)artly heat labile.
To examine the dose-response relationships of the stimulatory effect, sera from six individuals (one normal, one pregnant, one with AIP, and three with PCT) were heated to 60°C for 10 min to inactivate the inhibitory component, and aliquots from 10 to 200 A4 were added to culture vials. The resulting dose-response relationships are shown in Fig. 5 Separation of the serum stimulatory and inhibitory factors. An attempt was made to separate the serum components responsible for stimulation and inhibition of porphyrin formation by zone electrophoresis. A serum sample from a post partum woman which caused pronounced inhibition of porphyrin accumulation when untreated and strong stimulation of porphyrin accumulation when heated, was used. After dialysis, the effects of 17 serum fractions on liver cell porphyrin formation were examined both in control cultures and in cultures in which porphyrin formation was stimulated by etiocholanolone. Additional controls contained dialyzed barbital buffer. The electrophoresis procedure effectively separated the stimulatory and inhibitory activities. Stimulatory activity was located in the albumin region and inhibitory activity in the gamma region; both zones were broad (Fig. 6) . Moreover, since stimulatory and inhibitory activities were both evident after exhaustive dialysis, the responsible factors were not dialyzable.
The effects on porphyrin formation of dilutions of whole serum were compared to the effects of dilutions of the gamma globulin fraction which contained the inhibitory activity (Fig. 7) . As the concentration of whole serum, was diluted by adding decreasing amounts of serum to a constant volume of medium, the inhibitory activity declined, and stimulatory activity became apparent. However, when the fractions which inhibited porphyrin formation were progressively diluted, the inhibitory effect diminished, but no stimulation was observed. Moreover, while heated whole serum stimulated the formation of porphyrins, the heated fractions containing the inhibitory activity did not; the inhibitory effect was merely diminished. Thus 
DISCUSSION
These studies show that human sera contain separable factors which respectively stimulate and inhibit porphyrin formation in cultured chick embryo liver cells. The factor responsible for porphyrin stimulation in most sera was heat stable, insensitive to trypsin, present in supernates after ethanol precipitation of plasma proteins, absent in the precipitates, extractable in ethyl acetate, not extractable in less polar organic solvents, not dialyzable, and migratory with the albumin fraction of serum on electrophoresis. The factor responsible for inhibitory activity was heat labile, sensitive to trypsin, resistant to neuraminidase, present in the precipitates after ethanol precipitation of serum proteins, absent in the supernates, nondialyzable, and migratory with the gamma fraction of serum on electrophoresis. The stimulatory component does not appear to be a protein, unless it is a protein that is soluble in ethanol and insensitive to trypsin. However, since the stimulatory component was present in the albumin fraction after electrophoresis and could not be dialyzed, it is probably normally bound to a serum protein. Since ethanol extracts as well as the albumin-containing fraction of sera stimulated porphyrin formation, the factor responsible for the stimulation may be active either in the free or protein-bound state.
Strand and Marver (20) reported that normal serum acquired the capacity to stimulate porphyrin formation after f-glucuronidase hydrolysis, indicating that substances in sera which stimulate porphyrins may be conjugated to glucuronic acid and that the stimulatory factor is probably inactive in the conjugated state. Together, our data and those of Strand and Marver suggest that the stimulator may be a compound of small molecular weight, normally conjugated and protein bound. The inhibitory factor, on the other hand, appears to be a protein or a substance requiring tight binding to a protein for activity.
There have been no previous reports of substances in human sera that inhibit liver cell porphyrin formation. Sardesai and Orten (21) found an inhibitor of porphyrin formation by acetone powder preparations of beef liver in the plasma of dogs. Like the inhibitory factor we have observed in human sera, the canine factor was heat labile.
Substances that inhibit erythroid heme synthesis in human sera have been reported. The sera of certain patients with red cell aplasia (22) (23, 24) . It is possible that the inhibitor of heme synthesis in erythroid cells, and the inhibitor of porphyrin accumulation in hepatic cells (the latter also associated with the gamma globulin fraction of sera) may be related. Inhibitors of ervthropoietic henle formation have also been reported in sera from individutals at high altitudes (25) , newborn babies (26), anemic rats (27) , liypertransfused rats (28) , and in homogenates of rabbit liver, kidney, and spleen (29) ; however most have not been characterized. The last factor mentioned (29) was heat stable, which distinguishes it from the serum inhibition of porphyrin formation we have observed.
The pronounced inhibition of porphyrin formation by post partum sera is not, in all likelihood, attributable to prolactin, since human prolactin falls to prepregnant levels within 1 or 2 wk post partumn (30) , wlhile strong inhibition of porphyrin accumulation persiste(d for at least 6 wk post partumn, in both lactatinig anid nonlactating women. MIoreover, bovine prolactin added to liver cell cultures did not inhibit porphyrin formation. The possibility that the serum factor that inhlibits porphyrin formation may be an antibody whose productioni is increased post partuhn must be consideredl in light of the association of inhibitory activity witlh the serum gamma globulins. Elevated levels of IgM in sera of several post partum women have been reported (31) . The processes occurring during uterine involution in humans are not well understood, and it is also possible that the inhibitory factor may be a myoglobin derivative or another compound produced as a result of uterine involution.
Post partum sera inhibited porphyrin formation in control cultures, inhibited the stimulation of porphyrin formation by AIA and other drugs, and inhibited activity of ALAS. The number of porphyric subjects studied here was too small to draw conclusions about the role of the factors in the porphyrias. Although stimulatory activity appears to be increased in sera from patients with both AIP and PCT, high levels of stimulatory activity and clinical manifestations are not always related. Although a substance with the capacity to inhibit porphyrin formation could be detected in the sera of most porphyrics we studied, two subjects xvith AIP and three with PCT seemed to lack the inhibitory component. It is possible that porphyrias are .heterogeneous with respect to occurrence of the stimulatory and inhibitory factor and that the absence of the inhlibitory factor may play a pathogenetic role in certain patients with the disorders. A study of the effect onl porphyrin formation of serum from relatives of porphyria patients might show whether the occurrence of the factors was genetically determined and might aid in the understanding of the biochemical phenomenology of the porphyrias. It is also possible that a component in serum that can inhibit porphyrin formation may eventually prove useful in the therapeutic management of certain cases of porphyria.
